Drug Formulation Market 2026–2030 expanding with pharmaceutical advancements

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Drug Formulation Market During 2026–2030?

The drug formulation market has experienced robust expansion in recent times. This market is projected to expand from $2045.31 billion in 2025 to reach $2221.54 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 8.6%. Historically, this growth has been driven by factors such as the increased demand for generic drugs, the growing incidence of chronic diseases, breakthroughs in pharmaceutical research, the broadening reach of hospital and clinic networks, and escalating investments in research and development (R&D).

The drug formulation market is projected to experience substantial expansion over the upcoming period. Its valuation is anticipated to reach $3196.24 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.5%. This anticipated growth throughout the forecast timeframe can be linked to several factors, including the rise of gene and cell therapies, the integration of AI into drug design processes, the creation of innovative excipients, the escalating demand for biologics and specialty medications, and the enlargement of burgeoning pharmaceutical sectors. Significant trends anticipated during this period encompass tailored drug formulations, sophisticated drug delivery mechanisms, the advancement of biologics and biosimilars, enhancements in formulation stability and shelf-life, alongside a focus on regulatory adherence and quality control.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9900&type=smp

Which Major Factors Are Driving The Expansion Of The Drug Formulation Market?

The expanding embrace of personalized medicine is projected to boost the drug formulation market’s growth in the future. Personalized medicine represents a novel healthcare strategy, customizing medical treatments and interventions for the unique characteristics of every patient. This approach focuses on adapting therapies according to specific patient traits, including genetics and biomarkers. Consequently, it requires the creation of bespoke drug formulations to maximize effectiveness and safety for individual patients. Its influence extends to demanding individualized treatment strategies, formulations that incorporate genomic understanding, enhanced drug reactions, and specialized treatments for uncommon conditions. For example, in 2023, data from the Personalized Medicine Coalition (PMC), a US-based non-profit organization, indicated that personalized medicines constituted approximately 38 percent of all newly approved therapeutic molecular entities, an increase from 34 percent in 2022. Thus, the rising acceptance of personalized medicine is fueling expansion within the drug formulation market.

How Are The Various Segments Of The Drug Formulation Market Categorized?

The drug formulation market covered in this report is segmented –

1) By Dosage Form: Oral formulations, Parenteral Formulations, Topical Formulations, Inhalation Formulations

2) By Formulation: Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations

3) By Therapy Area: Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases

4) By End-User: Big Pharma, Small And Medium Pharma, Biotech Companies

Subsegments:

1) By Oral Formulations: Tablets, Capsules, Powders, Liquids Or Solutions

2) By Parenteral Formulations: Injectables, Implants, Infusions

3) By Topical Formulations: Creams, Ointments, Gels, Transdermal Patches

4) By Inhalation Formulations: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

What Trends Are Affecting The Expansion Of The Drug Formulation Market?

Major entities within the drug formulation market are engaged in developing novel fixed dose combination drugs for type 2 diabetes, aiming to secure a competitive edge. A Fixed Dose Combination (FDC) is defined as a pharmaceutical preparation that incorporates two or more active ingredients blended in a precise dose ratio within a single dosage form. As an illustration, in October 2023, Glenmark Pharmaceuticals Limited, an India-based pharmaceutical company, introduced its initial triple-drug fixed-dose combination, marketed as Zita DM. This product contains the DPP4 inhibitor, Teneligliptin (20mg), the SGLT2 inhibitor, Dapagliflozin, (10mg), and Metformin SR (500mg/1000mg) in a fixed dosage. It is prescribed for once-daily administration to enhance glycemic control in patients with Type 2 diabetes.

Which Major Firms Influence Developments In The Drug Formulation Market?

Major companies operating in the drug formulation market are AstraZeneca PLC, The Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., AbbVie Inc., C.H. Boehringer Sohn AG & Co. KG, F. Hoffmann-La Roche AG, Johnson & Johnson, Bayer AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A., GlaxoSmithKline plc, Novo Nordisk A/S, Amgen Inc., Viatris Inc., Sandoz International GmbH, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Limited, Torrent Pharmaceuticals Limited, Jubilant Life Sciences Limited, Cadila Healthcare Limited, Glenmark Pharmaceuticals Ltd., Wockhardt Ltd., Hikma Pharmaceuticals plc

Read the full drug formulation market report here:

https://www.thebusinessresearchcompany.com/report/drug-formulation-global-market-report

Which Region Currently Holds The Largest Share Of The Drug Formulation Market?

North America was the largest region in the drug formulation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the drug formulation market report during the forecast period. The regions covered in the drug formulation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Drug Formulation Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9900&type=smp

Browse Through More Reports Similar to the Global Drug Formulation Market 2026, By The Business Research Company

Drug Formulation Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-formulation-global-market-report

Oral Solid Dosage Pharmaceutical Formulation Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-pharmaceutical-formulation-global-market-report

Active Pharmaceutical Ingredients Market Report 2026

https://www.thebusinessresearchcompany.com/report/active-pharmaceutical-ingredients-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795